Bacterial acne foam - Foamix/Warner Chilcott
Latest Information Update: 16 Mar 2020
At a glance
- Originator Foamix; Warner Chilcott
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Acne
Most Recent Events
- 09 Mar 2020 Foamix has been acquired by Menlo Therapeutics
- 05 Jun 2013 No development reported - Preclinical for Acne in Israel (Topical)
- 12 Jan 2007 Preclinical trials in Acne in Israel (Topical)